GenturaDx is developing an automated, real-time PCR system that Austin, Texas-based Luminex (NASDAQ: LMNX) said will make fast, high-quality molecular diagnostics available to hospitals. The system should be available commercially by early 2014,Luminex said Monday.
No comments:
Post a Comment